Use of hip- versus wrist-based actigraphy for assessing functional decline and disease progression in patients with motor neuron disease.

Actigraphy outcomes measured from the wrist are more variable than from the hip and present differing sensitivity to specific functional outcomes. Outcomes and analysis should be carefully constructed to maximise benefit, should wrist-worn devices be used for at-home monitoring of disease progression in patients with MND.